Single-dose psilocybin for a treatment-resistant episode of major depression: Impact on patient-reported depression severity, anxiety, function, and quality of life

Goodwin, G. M., Aaronson, S. T., Alvarez, O., Atli, M., Bennett, J. C., Croal, M., DeBattista, C., Dunlop, B. W., Feifel, D., Hellerstein, D. J., Husain, M. I., Kelly, J. R., Lennard-Jones, M. R., Licht, R. W., Marwood, L., Mistry, S., Páleníček, T., Redjep, O., Repantis, D., … Malievskaia, E. (2023). Single-dose psilocybin for a treatment-resistant episode of major depression: Impact on patient-reported depression severity, anxiety, function, and quality of life. Journal of Affective Disorders, 327, 120–127. https://doi.org/10.1016/j.jad.2023.01.108
Authors:
Guy M Goodwin
Scott T Aaronson
Oscar Alvarez
Merve Atli
James C Bennett
Megan Croal
Charles DeBattista
Boadie W Dunlop
David Feifel
David J Hellerstein
Muhammad Ishrat Husain
John R Kelly
Molly R Lennard-Jones
Rasmus W Licht
Lindsey Marwood
Sunil Mistry
Tomáš Páleníček
Ozlem Redjep
Dimitris Repantis
Robert A Schoevers
Batya Septimus
Hollie J Simmons
Jair C Soares
Metten Somers
Susan C Stansfield
Jessica R Stuart
Hannah H Tadley
Nisha K Thiara
Joyce Tsai
Mourad Wahba
Sam Williams
Rachel I Winzer
Allan H Young
Matthew B Young
Sid Zisook
Ekaterina Malievskaia
Affiliated Authors:
David J Hellerstein
Subjects:
Author Keywords:
antidepressant
anxiety
patient-reported outcomes
psilocybin
psychedelic
treatment-resistant depression
Publication Type:
Article
Unique ID:
10.1016/j.jad.2023.01.108
PMID:
Publication Date:
Data Source:
PubMed

Record Created: